BORTEZOMIB (BORTENAT) INJECTION – TREATMENT FOR MULTIPLE MYELOMA AND MANTLE-CELL LYMPHOMA
Bortezomib or Bortenat Injection is a therapy for multiple myeloma and mantle cell lymphoma. It demonstrates its effectiveness by halting or reducing the growth of cancer cells.
Bortenat Injection is administered through injection by a trained medical expert. Your doctor will determine the appropriate dose and frequency of administration. This will vary depending on what you are being treated for and may alter over time.
When you have multiple myeloma, your body destroys bone quicker than it replaces it. This causes bones to become weak, painful, and prone to breaking. Bortenat Injection therapy may be used in conjunction with other cancer treatments such as chemotherapy. It is an important aspect of your treatment and helps people with multiple myeloma live longer lives. This medication will eliminate the malignant cells and prevent them from growing and spreading to other places of the body.
USES OF BORTEZOMIB (BORTENAT) INJECTION
- Multiple myeloma
- Mantle-cell lymphoma
WORKS OF BORTEZOMIB (BORTENAT) INJECTION
Bortenat Injection is a cancer-fighting drug. It works by preventing or decreasing protein degradation in cells. As a result, the number of proteins in cancer cells rises, leading to their demise.
SIDE EFFECTS OF BORTEZOMIB (BORTENAT) INJECTION
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Low blood platelets
- Peripheral neuropathy (tingling and numbness of feet and hands)
- Psychiatric disturbances
- Loss of appetite
- Anemia (low number of red blood cells)
- Decreased appetite
- Decreased white blood cell count (neutrophils)
WARNING & PRECAUTIONS
Bortenat Injection may create negative effects that impair your ability to drive.
Bortenat Injection may produce fatigue, dizziness, fainting, or impaired vision, which may impair your ability to drive.
In patients with severe kidney disease, Bortenat Injection should be used with caution. Bortenat Injection dosage may need to be adjusted. Please consult your physician.
There is little information on the usage of Bortenat Injection in these patients.
In patients with liver problems, Bortenat Injection should be taken with caution. Bortenat Injection dosage may need to be adjusted. Please consult your physician.
Bortenat Injection should not be used during pregnancy because there is clear evidence of danger to the developing infant. However, if the advantages outweigh the hazards, the doctor may seldom prescribe it in life-threatening conditions. Please consult your physician.
Fedelty Health Care is a Bortezomib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.